P&G teams with Communities In Schools, John Legend to launch new GIVE Education campaign
NEW YORK — Procter & Gamble and Communities In Schools, one of the nation’s leading dropout prevention organizations, on Tuesday announced the launch of GIVE Education, a new campaign developed to increase awareness of the student dropout crisis in the United States.
P&G has pledged to donate 2 cents to CIS for each BrandSAVER coupon redeemed by consumers starting on Sunday, July 31, in an uncapped donation. The coupons will be distributed in newspapers across the country with discounts for P&G products from such brands as Puffs, Bounty, Crest, Pantene, Duracell, Olay and Tide. A list of newspapers carrying the coupons can be found at PGEverydaySolutions.com.
“We’re making it easy for consumers to make a difference,” said Jim Leish, director of U.S. operations for P&G North America, at a press conference in New York announcing the campaign. “Joining forces with CIS and John Legend allows us to support the incredibly important work they do in empowering students to learn and thrive.”
“All kids deserve the chance to learn and to succeed,” added Grammy-award-winning artist John Legend, who is serving as the campaign spokesman. “By teaming up with P&G and CIS on the GIVE Education campaign, I can further support a cause of great importance to me — ensuring that all kids receive a quality education, regardless of where they grow up.”
For more on the campaign and to see the commercial featuring John Legend, visit Facebook.com/PGMyGive. P&G also noted at the press event that for each view of the video on the campaign’s Facebook page, the company will make an additional donation to CIS.
No comments found
FDA to sponsor Twitter chat on proposed guidelines for health-related apps
SILVER SPRING, Md. — The Food and Drug Administration will sponsor a chat session via Twitter concerning proposed guidelines for health-related apps, the agency said Tuesday.
The chat session will begin at 3 p.m. on Twitter.com/US_FDA.
A wide variety of health apps have become available for smartphones in recent years, and the FDA is responding by proposing guidelines affecting medical apps that the agency said could present a risk to patients if they don’t work as intended. The guidelines are scheduled to be posted on the Federal Register website and to appear in print on Wednesday.
More fiscally irresponsible regulation from the FDA. Big surprise. Medical apps are a small proportion of our medical devices. 50% of our medical devices and 80% of our pharmaceuticals are imported according to the FDA themselves in their report Pathway to Global Product Safety and Quality. They also said themselves that “The safety of America’s food and medical products remains under serious threat… it would take 9 years just to inspect every high-priority pharmaceutical facility alone, let alone those of lower priority.” The FDA is lacking in resources and manpower. The FDA’s budget was slashed recently by 258 million. This new set of regulations is only one instance of new regulations that are taking away resources from more important areas. This lack of resources has made the 2011 Food Safety and Modernization Act reactionary instead of preventative as the FDA will need to establish a myriad of partnerships, coalitions and improved intelligence-gathering techniques. Even then, resources will still be deployed on “data-driven risk analytics.” Hardly all-inclusive, hardly preventative. By overregulating this new field of technology and handing over monopolies to big pharma, we crush innovation. Many companies, especially small tech startups cannot afford the increased research. For example since 1968 about 41 less new pharmaceuticals have been approved each year according to the Independent Institute and even more aren’t even researched due to the costs associated. Initially, for the first 86 years of FDA's existence, from 1906-1992the U.S. treasury department funded the FDA. In 1992 a law passed allowing pharmaceutical companies to provide funding for their own research that smaller companies could not put forth. Once again the FDA kills growth and initiative in favor of Big Pharma.
Mark Tuffin takes reins at Smith’s
CINCINNATI — Kroger banner Smith’s has a new president.
Mark Tuffin will succeed Jim Hallsey, who is retiring from his post after 47 years of service with Smith’s and Kroger, the supermarket retailer announced Tuesday. Hallsey served in his role as president of Smith’s since 2001.
Tuffin, who most recently served as Kroger’s VP transition, leading the company’s efforts to implement significant organizational changes between all areas of the business, brings more than 30 years of experience to his new role. Tuffin joined Smith’s in 1996.
"Mark possesses remarkable leadership skills and experience in both the Smith’s division and leading Kroger’s transition efforts," Kroger president and COO Rodney McMullen said. "Despite the challenges of organizational change, he never lost sight of our core mission to put the customer first. We are pleased Mark has accepted this new role."
Smith’s operates 133 stores throughout seven Western states.
No comments found